Biogen up as earnings top estimates

Biogen Idec Inc. (NASDAQ:BIIB) jumped $35.58 (10%) to $388.83 on Friday, reaching an all-time high after its 4Q14 earnings beat the Street.

The company's 4Q14 non-GAAP diluted EPS was $4.09, up 75% from $2.34 in the previous year's quarter and beat the Street estimate by $0.31. Biogen issued guidance of $16.60-$17 for 2015 non-GAAP diluted EPS on revenue growth of 14-16%, above analysts' estimates of $16.37. ...